Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS

Inclusion Criteria: * Generally healthy at screening; * Body weight ≥ 50 kg for men and ≥ 45 kg for women; * Sitting blood pressure ≤ 135/90 mmHg; * Demonstrating negative hIV, HBsAG and DCV-Ab screen tests; * Women of child-bearing potential must be non-pregnant, non-lactating, and practicing a clinically acceptable form of birth control; * Properly consented * Other criteria apply Exclusion Criteria: * A smoking history of ≥10 pack-years, or having smoked within 6 months prior to Screening; * Upper respiratory tract infections within 2 wk, or lower respiratory tract infection within 4 wk, prior to Screening; * Any current or recent respiratory conditions that might significantly affect pharmacodynamic response to the study drugs; * Known intolerance or hypersensitivity to the study MDI ingredients; * Having been on other investigational drug/device studies, or donated blood, in the last 30 days prior to Screening; * Other criteria apply